| Product Code: ETC7644893 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Angiogenesis Inhibitors Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Angiogenesis Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Angiogenesis Inhibitors Market - Industry Life Cycle |
3.4 Israel Angiogenesis Inhibitors Market - Porter's Five Forces |
3.5 Israel Angiogenesis Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Angiogenesis Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Angiogenesis Inhibitors Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Israel Angiogenesis Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Angiogenesis Inhibitors Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Israel Angiogenesis Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Angiogenesis Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing adoption of angiogenesis inhibitors in cancer treatment |
4.2.3 Rising investments in research and development of innovative angiogenesis inhibitors |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with angiogenesis inhibitors |
4.3.3 Potential side effects and toxicity concerns of angiogenesis inhibitors |
5 Israel Angiogenesis Inhibitors Market Trends |
6 Israel Angiogenesis Inhibitors Market, By Types |
6.1 Israel Angiogenesis Inhibitors Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Angiogenesis Inhibitors Market Revenues & Volume, By VEGF Targeted Therapy, 2021- 2031F |
6.1.4 Israel Angiogenesis Inhibitors Market Revenues & Volume, By FGF Targeted Therapies, 2021- 2031F |
6.1.5 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Oncogene Targeted Therapy, 2021- 2031F |
6.1.6 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Matrix Degrading and Remodeling Targeted Therapy, 2021- 2031F |
6.1.7 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Angiogenesis Inhibitors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.2.3 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Angiogenesis Inhibitors Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Inlyta, 2021- 2031F |
6.3.3 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Avastin, 2021- 2031F |
6.3.4 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Revlimid, 2021- 2031F |
6.3.5 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Angiogenesis Inhibitors Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Angiogenesis Inhibitors Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Angiogenesis Inhibitors Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Israel Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Angiogenesis Inhibitors Market Import-Export Trade Statistics |
7.1 Israel Angiogenesis Inhibitors Market Export to Major Countries |
7.2 Israel Angiogenesis Inhibitors Market Imports from Major Countries |
8 Israel Angiogenesis Inhibitors Market Key Performance Indicators |
8.1 Number of clinical trials involving angiogenesis inhibitors in Israel |
8.2 Rate of adoption of novel angiogenesis inhibitors in cancer treatment |
8.3 Investment trends in Israeli biopharmaceutical companies developing angiogenesis inhibitors |
9 Israel Angiogenesis Inhibitors Market - Opportunity Assessment |
9.1 Israel Angiogenesis Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Angiogenesis Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Angiogenesis Inhibitors Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Israel Angiogenesis Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Angiogenesis Inhibitors Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Israel Angiogenesis Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Angiogenesis Inhibitors Market - Competitive Landscape |
10.1 Israel Angiogenesis Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Israel Angiogenesis Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here